NEW YORK (GenomeWeb News) — Illumina has licensed Oxford Gene Technology patents that will enable Illumina to detect DNA sequence variations, OGT said today.
 
Under the deal, OGT has granted Illumina access to the property through the life of the patents and provides “certain rights with respect to SNP genotyping,” OGT said.
 
Illumina CEO Jay Flatley said the licensing agreement is “relevant to a portion of our products and will not materially impact our expected financial results."
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.